Internal Medicine, Medical Oncology · Lakeland, FL
NPI
1427048537
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1730 Lakeland Hills Blvd
Lakeland, FL, 33805
Phone (863) 603-4770
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
305,188 services
Medicare patients, 2024
1,306
Average age 76
Drug cost, 2024
$9.1M
6,017 prescriptions
Company payments, 2025
$1,729
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shalini Mulaparthi was code J1439 (injection, ferric carboxymaltose, 1 mg), 48,000 times for 32 patients. In total Shalini Mulaparthi billed 305,188 services in 137 codes, and Medicare paid $4.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 48,000 | 32 | $0.87 | $42K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 24,800 | 25 | $44.24 | $1.1M |
| J0897 Injection, denosumab, 1 mg | Office | 15,960 | 35 | $20.51 | $327K |
| J9267 Injection, paclitaxel, 1 mg | Office | 12,491 | 16 | $0.08 | $1,006 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 10,350 | 18 | $0.11 | $1,140 |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 7,820 | 22 | $4.38 | $34K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,060 | 15 | $6.49 | $33K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,019 | 58 | $0.09 | $266 |
| 99214 Office E&M - Established | Office | 2,328 | 1,082 | $94.50 | $220K |
| J9395 Injection, fulvestrant, 25 mg | Office | 1,640 | 13 | $6.34 | $10K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,530 | 32 | $0.71 | $1,091 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,359 | 875 | $12.42 | $17K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,300 | 29 | $0.07 | $95.08 |
| 96372 Injection Administration | Office | 963 | 158 | $10.55 | $10K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 946 | 12 | $3.59 | $3,398 |
By year: 2022 $5.6M for 361,328 services; 2023 $5.4M for 289,755 services; 2024 $4.9M for 305,188 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shalini Mulaparthi prescribed most often to Medicare patients was Anastrozole, with 801 prescriptions and refills. In total Shalini Mulaparthi wrote 6,017 Medicare prescriptions that cost $9.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 801 | 1,919 | 207 | $13K |
| Gabapentin Generic | 303 | 398 | 73 | $3,211 |
| Pantoprazole Sodium Generic | 299 | 616 | 97 | $2,618 |
| Letrozole Generic | 224 | 565 | 65 | $5,857 |
| Ondansetron Hcl Generic | 182 | 182 | 85 | $1,820 |
| Tamoxifen Citrate Generic | 182 | 460 | 49 | $4,789 |
| Eliquis Apixaban | 166 | 250 | 36 | $134K |
| Potassium Chloride Generic | 158 | 197 | 66 | $1,039 |
| Levothyroxine Sodium Generic | 152 | 293 | 36 | $910 |
| Dexamethasone Generic | 147 | 152 | 41 | $1,551 |
| Acyclovir Generic | 129 | 216 | 24 | $1,806 |
| Exemestane Generic | 108 | 258 | 30 | $15K |
| Prednisone Generic | 102 | 122 | 51 | $376 |
| Imbruvica Ibrutinib | 83 | 83 | Under 11 | $1.4M |
| Bicalutamide Generic | 82 | 191 | 25 | $2,804 |
Brand drugs: - claims; generic drugs: 5,019 claims; opioid claims: 234.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shalini Mulaparthi $1,729 ($1,729 in general payments such as food, travel and fees) from 31 companies. The largest payer was Pfizer Inc. with $286.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 14 | $286 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $183 |
| Janssen Biotech, Inc. JNJ | 3 | $148 |
| Genzyme Corporation SNY | 5 | $102 |
| Seagen Inc. PFE | 1 | $99.99 |
| Incyte Corporation INCY | 1 | $99.95 |
| Celgene Corporation BMY | 3 | $81.63 |
| Array Biopharma Inc PFE | 3 | $75.74 |
| Gilead Sciences, Inc. GILD | 3 | $68.91 |
| GlaxoSmithKline, LLC. GSK | 2 | $53.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.